{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:00:25Z","timestamp":1783749625416,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>The COVID-19 pandemic and the associated post-acute sequelae of COVID-19 (PASC) have led to the identification of a complex disease phenotype that is associated with important changes in the immune system. Herein, we describe a unique case of <jats:italic>Nocardia farcinica<\/jats:italic> cerebral abscess in an individual with sudden immunodeficiency several months after mild COVID-19. Intravenous Bactrim and Imipenem were prescribed for 6 weeks. After this, a 12-month course of Bactrim and Clavulin was prescribed to be taken orally, given the <jats:italic>N. farcinica<\/jats:italic> infection at the level of the central nervous system. This case report highlights the need for future research into the pathophysiology of COVID-19 and PASC immune dysregulation in convalescent individuals. It also draws attention to the need for timely consideration of opportunistic infections in patients with a history of COVID-19.<\/jats:p>","DOI":"10.3389\/fneur.2023.1137024","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T08:59:13Z","timestamp":1677056353000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Encephalic nocardiosis after mild COVID-19: A case report"],"prefix":"10.3389","volume":"14","author":[{"given":"Nadia","family":"Bouhamdani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Comeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41584-021-00608-z","article-title":"Systemic and organ-specific immune-related manifestations of COVID-19","volume":"17","author":"Ramos-Casals","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B2","unstructured":"COVID-19 Rapid Guideline: Managing the Long-term Effects of COVID-19 NICE Guideline [NG188]2020"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.20.21253896","article-title":"Challenges in defining Long COVID: striking differences across literature, electronic health records, and patient-reported information","author":"Rando","year":"2021","journal-title":"medRxiv."},{"key":"B4","doi-asserted-by":"publisher","first-page":"m3026","DOI":"10.1136\/bmj.m3026","article-title":"A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care","volume":"370","author":"Greenhalgh","year":"2020","journal-title":"BMJ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/thoraxjnl-2020-216377","article-title":"Persistent symptoms 15-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study","volume":"76","author":"Stavem","year":"2021","journal-title":"Thorax."},{"key":"B6","doi-asserted-by":"publisher","first-page":"m2815","DOI":"10.1136\/bmj.m2815","article-title":"Covid-19: what do we know about \u201clong covid\u201d?","volume":"370","author":"Mahase","year":"2020","journal-title":"BMJ."},{"key":"B7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S1473-3099(15)70152-0","article-title":"Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study","volume":"15","author":"Clark","year":"2015","journal-title":"Lancet Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1440-1843.2010.01720.x","article-title":"The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status","volume":"15","author":"Ngai","year":"2010","journal-title":"Respirology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12916-021-02228-6","article-title":"Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection","volume":"20","author":"Ryan","year":"2022","journal-title":"BMC Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e140491","DOI":"10.1172\/JCI140491","article-title":"Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection","volume":"131","author":"Files","year":"2021","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-020-00187-5","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell Discov."},{"key":"B13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s15010-009-9193-9","article-title":"Nocardiosis: updated clinical review and experience at a tertiary center","volume":"38","author":"Ambrosioni","year":"2010","journal-title":"Infection."},{"key":"B14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/01.md.0000141100.30871.39","article-title":"A case series and focused review of nocardiosis: clinical and microbiologic aspects","volume":"83","author":"Lederman","year":"2004","journal-title":"Medicine."},{"key":"B15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0732-8893(95)00249-9","article-title":"Adrenal insufficiency, recurrent bacteremia, and disseminated abscesses caused by Nocardia asteroides in a patient with acquired immunodeficiency syndrome","volume":"24","author":"Arabi","year":"1996","journal-title":"Diagn Microbiol Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s100960050460","article-title":"Infection caused by Nocardia farcinica: case report and review","volume":"19","author":"Torres","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1128\/jcm.28.12.2726-2732.1990","article-title":"Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica","volume":"28","author":"Wallace","year":"1990","journal-title":"J Clin Microbiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1086\/314450","article-title":"Nocardia farcinica sternotomy site infections in patients following open heart surgery","volume":"178","author":"Wenger","year":"1998","journal-title":"J Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/clinids\/23.5.1165","article-title":"Disseminated and cerebral infection due to Nocardia farcinica: diagnosis by blood culture and cure with antibiotics alone","volume":"23","author":"Peters","year":"1996","journal-title":"Clin Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/00000441-196803000-00008","article-title":"Nocardial brain abscess cured with cycloserine and sulfonamides","volume":"255","author":"Hoeprich","year":"1968","journal-title":"Am J Med Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/archinte.143.4.711","article-title":"Trimethoprim-sulfamethoxazole therapy for Nocardia infections","volume":"143","author":"Smego","year":"1983","journal-title":"Arch Intern Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu Rev Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2249.1996.tb08306.x","article-title":"Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes","volume":"103","author":"Lanza","year":"1996","journal-title":"Clin Exp Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.7326\/0003-4819-84-3-304","article-title":"Glucocorticosteroid therapy: mechanisms of action and clinical considerations","volume":"84","author":"Fauci","year":"1976","journal-title":"Ann Intern Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.4049\/jimmunol.151.8.4081","article-title":"Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor","volume":"151","author":"Paliogianni","year":"1993","journal-title":"J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e01599","DOI":"10.1016\/j.idcr.2022.e01599","article-title":"Nocardiosis of the central nervous system: a rare complication of COVID management?","volume":"29","author":"DiMeglio","year":"2022","journal-title":"IDCases."},{"key":"B27","doi-asserted-by":"publisher","first-page":"686029","DOI":"10.3389\/fimmu.2021.686029","article-title":"Unraveling the mystery surrounding post-acute sequelae of COVID-19","volume":"12","author":"Ramakrishnan","year":"2021","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"m1328","DOI":"10.1136\/bmj.m1328","article-title":"Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal","volume":"369","author":"Wynants","year":"2020","journal-title":"BMJ."},{"key":"B29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.molimm.2021.06.001","article-title":"Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression","volume":"138","author":"Mahmoodpoor","year":"2021","journal-title":"Mol Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nat Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e247893","DOI":"10.1136\/bcr-2021-247893","article-title":"Quantitative B and T cell abnormalities in four patients presenting with mucormycosis and prior asymptomatic COVID-19 infection","volume":"15","author":"Mandke","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"iqaa007","DOI":"10.1093\/oxfimm\/iqaa007","article-title":"T cell phenotypes in COVID-19 - a living review","volume":"2","author":"Hanna","year":"2021","journal-title":"Oxf Open Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.4049\/jimmunol.129.4.1688","article-title":"Enhanced resistance to Nocardia brasiliensis infection in mice depleted of antigen-specific B cells","volume":"129","author":"Rico","year":"1982","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1128\/CMR.7.2.213","article-title":"Nocardia species: host-parasite relationships","volume":"7","author":"Beaman","year":"1994","journal-title":"Clin Microbiol Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.mayocp.2011.11.016","article-title":"Nocardiosis: updates and clinical overview","volume":"87","author":"Wilson","year":"2012","journal-title":"Mayo Clin Proc."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1137024\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T08:59:17Z","timestamp":1677056357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1137024\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":38,"alternative-id":["10.3389\/fneur.2023.1137024"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1137024","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"article-number":"1137024"}}